Teriparatide

Product NDC
0093-1106
11-digit product format
000931106
Labeler code
0093
Product ID
0093-1106_5e3977c0-a361-494b-ac07-0426dda5bd36
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Teriparatide
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Teva Pharmaceuticals USA, Inc.
Application
ANDA208569
Marketing category
ANDA
Marketing start
2023-12-18
Substance
TERIPARATIDE ACETATE
Active strength
250 ug/mL
Pharmacologic classes
Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208569-001TERIPARATIDETERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A208569-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A208569-001TERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208569-001TERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08A208569-001TERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208569-001TERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-168072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-166a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-161c564ffb4f44…
2023-12-20 04:57 UTC2023-12A208569-001TERIPARATIDE0.6MG/2.4ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16ea1830bbd6c7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208569-001TERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION / SUBCUTANEOUSAP2023-11-16a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A208569-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208569-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A208569-001AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208569-001AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208569-001AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208569-001AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208569-001AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208569-001AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A208569-001AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A208569-001AP1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A208569-001AP179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A208569-001AP1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A208569-001AP11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A208569-001AP18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A208569-001AP16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A208569-001AP11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A208569-001AP1ea1830bbd6c7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208569-001AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Teriparatide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TERIPARATIDE ACETATE250 ug/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9959P4V12NInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1435115Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d371f0f7-d492-4481-b360-051456d56d65Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b921a6be-c897-e1d4-f6d7-f4df8c2a7a6aProduct name220250731
bc54407b-4c2b-4714-a018-cf90828b0cb1Product name120250317
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
25117fd6-247a-42b6-bd01-89f9877d0f51Product name120200304
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0093-1106-16Teriparatide1 in 1 CARTONINJECTION, SOLUTION13
0093-1106-16Teriparatide2.24 mL in 1 SYRINGEINJECTION, SOLUTION2.243

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0093-1106-16ML - Milliliter0093-1106f8f1e34b-7c71-4d3f-ae6a-d3b50d9b019512024-01-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0093-1106TERIPARATIDE INJECTION, SOLUTION [TEVA PHARMACEUTICALS USA, INC.]3Current NDC, 2 package rows20250313_d371f0f7-d492-4481-b360-051456d56d65.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TeriparatideTERIPARATIDETeva Pharmaceuticals USA, Inc.d371f0f7-d492-4481-b360-051456d56d652024-09-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208569
application number: ANDA208569
ndc (product): 0093-1106

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1435115teriparatide 20 MCG/Dose in 28 Dose Pen InjectorPSNd371f0f7-d492-4481-b360-051456d56d653
143511528 ACTUAT teriparatide 0.02 MG/ACTUAT Pen InjectorSCDd371f0f7-d492-4481-b360-051456d56d653
1435115teriparatide 0.02 MG/ACTUAT Pen Injector, 28 ACTUATSYd371f0f7-d492-4481-b360-051456d56d653
1435115teriparatide 20 MCG/ACTUAT Pen Injector, 28 ACTUATSYd371f0f7-d492-4481-b360-051456d56d653

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0093-1106-16000931106161 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGE1 syringe2023-12-18NoNoCurrent